New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 5, 2014
06:10 EDTEVARLombard Medical announces Aorfix received approval in Japan
Lombard Medical announced that its lead product, Aorfix, an endovascular stent graft to treat AAA, has received approval from the Japanese Ministry of Health, Labour and Welfare. Commercial sales will follow reimbursement approval, which the Company anticipates receiving in September. Aorfix will be exclusively distributed by Medico's Hirata.
News For EVAR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
16:04 EDTEVARLombard Medical sees Q1 revenue $3M-$3.3M, consensus $4.87M
Subscribe for More Information
16:03 EDTEVARLombard Medical sees FY15 revenue $18M-$20M, consensus $23.45M
Subscribe for More Information
16:02 EDTEVARLombard Medical reports Q4 EPS (51c), consensus (54c)
Reports Q4 revenue $4.8M, consensus $4.8M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use